[M04AX02, pegloticase, The risk or severity of adverse effects can be increased when Febuxostat is combined with Pegloticase.]
[L01BB02, mercaptopurine, The serum concentration of Mercaptopurine can be increased when it is combined with Febuxostat.]
[L02BA01, tamoxifen, The excretion of Tamoxifen can be decreased when combined with Febuxostat.]
[L01CB02, teniposide, The excretion of Teniposide can be decreased when combined with Febuxostat.]
[G03BA03, testosterone, The excretion of Testosterone can be decreased when combined with Febuxostat.]
[R03DA07, theobromine, The serum concentration of the active metabolites of Theobromine can be increased when Theobromine is used in combination with Febuxostat.]
[R03DA04, theophylline, The serum concentration of the active metabolites of Theophylline can be increased when Theophylline is used in combination with Febuxostat.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Febuxostat.]
[C03AA06, trichlormethiazide, The therapeutic efficacy of Febuxostat can be decreased when used in combination with Trichlormethiazide.]
[B01AF01, rivaroxaban, The excretion of Rivaroxaban can be decreased when combined with Febuxostat.]
[L01CA02, vincristine, The excretion of Vincristine can be decreased when combined with Febuxostat.]
[J05AF01, zidovudine, The excretion of Zidovudine can be decreased when combined with Febuxostat.]
[J05AE02, indinavir, The metabolism of Febuxostat can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The excretion of Vemurafenib can be decreased when combined with Febuxostat.]
[S01LA01, verteporfin, Febuxostat may increase the photosensitizing activities of Verteporfin.]
[L04AX01, azathioprine, The metabolism of Azathioprine can be decreased when combined with Febuxostat.]
[L04AA31, teriflunomide, The excretion of Teriflunomide can be decreased when combined with Febuxostat.]
[L01EX05, regorafenib, The metabolism of Febuxostat can be decreased when combined with Regorafenib.]
[J05AE04, nelfinavir, The metabolism of Febuxostat can be increased when combined with Nelfinavir.]
[N06DA02, donepezil, The excretion of Donepezil can be decreased when combined with Febuxostat.]
[L01EA05, ponatinib, The excretion of Ponatinib can be decreased when combined with Febuxostat.]
[B01AF02, apixaban, The excretion of Apixaban can be decreased when combined with Febuxostat.]
[C03AA01, bendroflumethiazide, The therapeutic efficacy of Febuxostat can be decreased when used in combination with Bendroflumethiazide.]
[A06AX06, tegaserod, The excretion of Tegaserod can be decreased when combined with Febuxostat.]
[M01AH01, celecoxib, The excretion of Celecoxib can be decreased when combined with Febuxostat.]
[L01EC02, dabrafenib, The excretion of Dabrafenib can be decreased when combined with Febuxostat.]
[L01EB03, afatinib, The excretion of Afatinib can be decreased when combined with Febuxostat.]
[J05AJ03, dolutegravir, The excretion of Dolutegravir can be decreased when combined with Febuxostat.]
[C02KX05, riociguat, The excretion of Riociguat can be decreased when combined with Febuxostat.]
[J05AP05, simeprevir, The excretion of Simeprevir can be decreased when combined with Febuxostat.]
[J05AP08, sofosbuvir, The excretion of Sofosbuvir can be decreased when combined with Febuxostat.]
[L01EM01, idelalisib, The excretion of Idelalisib can be decreased when combined with Febuxostat.]
[J05AP09, dasabuvir, The metabolism of Febuxostat can be decreased when combined with Dasabuvir.]
[L01EF01, palbociclib, The excretion of Palbociclib can be decreased when combined with Febuxostat.]
[L01EX08, lenvatinib, The excretion of Lenvatinib can be decreased when combined with Febuxostat.]
[J02AC05, isavuconazole, The metabolism of Febuxostat can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, The excretion of Osimertinib can be decreased when combined with Febuxostat.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Febuxostat.]
[L01XX52, venetoclax, The excretion of Venetoclax can be decreased when combined with Febuxostat.]
[L01XK03, rucaparib, The excretion of Rucaparib can be decreased when combined with Febuxostat.]
[R03DA08, bamifylline, The serum concentration of the active metabolites of Bamifylline can be increased when Bamifylline is used in combination with Febuxostat.]
[N06BC01, caffeine, The serum concentration of the active metabolites of Caffeine can be increased when Caffeine is used in combination with Febuxostat.]
[J05AE09, tipranavir, The metabolism of Febuxostat can be increased when combined with Tipranavir.]
[L01ED04, brigatinib, The excretion of Brigatinib can be decreased when combined with Febuxostat.]
[J01MA23, delafloxacin, The excretion of Delafloxacin can be decreased when combined with Febuxostat.]
[L01XX59, enasidenib, The excretion of Enasidenib can be decreased when combined with Febuxostat.]
[L01EM02, copanlisib, The excretion of Copanlisib can be decreased when combined with Febuxostat.]
[L01EF03, abemaciclib, The excretion of Abemaciclib can be decreased when combined with Febuxostat.]
[J05AG03, efavirenz, The metabolism of Febuxostat can be increased when combined with Efavirenz.]
[A10BK04, ertugliflozin, The excretion of Ertugliflozin can be decreased when combined with Febuxostat.]
[N03AF01, carbamazepine, The metabolism of Febuxostat can be increased when combined with Carbamazepine.]
[B02BX09, fostamatinib, The metabolism of Febuxostat can be decreased when combined with Fostamatinib.]
[N03AX24, cannabidiol, The metabolism of Febuxostat can be decreased when combined with Cannabidiol.]
[B02BX07, lusutrombopag, The excretion of Lusutrombopag can be decreased when combined with Febuxostat.]
[L01EM04, duvelisib, The excretion of Duvelisib can be decreased when combined with Febuxostat.]
[L01EB07, dacomitinib, The excretion of Dacomitinib can be decreased when combined with Febuxostat.]
[R03DA02, oxtriphylline, The serum concentration of the active metabolites of Oxtriphylline can be increased when Oxtriphylline is used in combination with Febuxostat.]
[L01XK04, talazoparib, The excretion of Talazoparib can be decreased when combined with Febuxostat.]
[R03BB08, revefenacin, The excretion of Revefenacin can be decreased when combined with Febuxostat.]
[L01XJ03, glasdegib, The excretion of Glasdegib can be decreased when combined with Febuxostat.]
[L01EM03, alpelisib, The serum concentration of Alpelisib can be increased when it is combined with Febuxostat.]
[L02BB06, darolutamide, The excretion of Darolutamide can be decreased when combined with Febuxostat.]
[L01EX15, pexidartinib, The metabolism of Febuxostat can be decreased when combined with Pexidartinib.]
[C03AA09, cyclothiazide, The therapeutic efficacy of Febuxostat can be decreased when used in combination with Cyclothiazide.]
[G03AC09, desogestrel, The metabolism of Febuxostat can be increased when combined with Desogestrel.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be increased when it is combined with Febuxostat.]
[L01XX72, tazemetostat, The excretion of Tazemetostat can be decreased when combined with Febuxostat.]
[N02CD06, rimegepant, The serum concentration of Rimegepant can be increased when it is combined with Febuxostat.]
[L04AA38, ozanimod, Febuxostat may decrease the excretion rate of Ozanimod which could result in a higher serum level.]
[L01EE04, selumetinib, The excretion of Selumetinib can be decreased when combined with Febuxostat.]
[L01XD01, porfimer sodium, Febuxostat may increase the photosensitizing activities of Porfimer sodium.]
[L01EH03, tucatinib, The excretion of Tucatinib can be decreased when combined with Febuxostat.]
[L01EX19, ripretinib, The excretion of Ripretinib can be decreased when combined with Febuxostat.]
[J05AX29, fostemsavir, The excretion of Fostemsavir can be decreased when combined with Febuxostat.]
[L01EX23, pralsetinib, The excretion of Pralsetinib can be decreased when combined with Febuxostat.]
[C03AA04, chlorothiazide, The therapeutic efficacy of Febuxostat can be decreased when used in combination with Chlorothiazide.]
[B06AC06, berotralstat, The serum concentration of Berotralstat can be increased when it is combined with Febuxostat.]
[V03AF12, trilaciclib, The excretion of Trilaciclib can be decreased when combined with Febuxostat.]
[N06BA10, fenethylline, The serum concentration of the active metabolites of Fenethylline can be increased when Fenethylline is used in combination with Febuxostat.]
[M01AG01, mefenamic acid, The metabolism of Febuxostat can be decreased when combined with Mefenamic acid.]
[L01EA06, asciminib, The metabolism of Febuxostat can be decreased when combined with Asciminib.]
[B06AX04, mitapivat, The metabolism of Febuxostat can be increased when combined with Mitapivat.]
[L04AA13, leflunomide, The excretion of Leflunomide can be decreased when combined with Febuxostat.]
[L01EA01, imatinib, The excretion of Imatinib can be decreased when combined with Febuxostat.]
[N03AX09, lamotrigine, The metabolism of Febuxostat can be increased when combined with Lamotrigine.]
[C03AA07, cyclopenthiazide, The therapeutic efficacy of Febuxostat can be decreased when used in combination with Cyclopenthiazide.]
[C10AA07, rosuvastatin, The excretion of Rosuvastatin can be decreased when combined with Febuxostat.]
[L01DA01, dactinomycin, The excretion of Dactinomycin can be decreased when combined with Febuxostat.]
[L01DB02, daunorubicin, The excretion of Daunorubicin can be decreased when combined with Febuxostat.]
[G03XX01, prasterone, The excretion of Prasterone can be decreased when combined with Febuxostat.]
[C01CA23, theodrenaline, The serum concentration of the active metabolites of Theodrenaline can be increased when Theodrenaline is used in combination with Febuxostat.]
[L01XA03, oxaliplatin, The excretion of Oxaliplatin can be decreased when combined with Febuxostat.]
[L01EB01, gefitinib, The excretion of Gefitinib can be decreased when combined with Febuxostat.]
[C04AD01, pentifylline, The serum concentration of the active metabolites of Pentifylline can be increased when Pentifylline is used in combination with Febuxostat.]
[J05AF02, didanosine, The serum concentration of Didanosine can be increased when it is combined with Febuxostat.]
[L01EB02, erlotinib, The metabolism of Febuxostat can be decreased when combined with Erlotinib.]
[N02BA11, diflunisal, The metabolism of Febuxostat can be decreased when combined with Diflunisal.]
[C10AX09, ezetimibe, The excretion of Ezetimibe can be decreased when combined with Febuxostat.]
[J05AE08, atazanavir, The metabolism of Febuxostat can be decreased when combined with Atazanavir.]
[N06BC02, propentofylline, The serum concentration of the active metabolites of Propentofylline can be increased when Propentofylline is used in combination with Febuxostat.]
[R03DA03, proxyphylline, The serum concentration of the active metabolites of Proxyphylline can be increased when Proxyphylline is used in combination with Febuxostat.]
[N07XX02, riluzole, The excretion of Riluzole can be decreased when combined with Febuxostat.]
[L01DB01, doxorubicin, The excretion of Doxorubicin can be decreased when combined with Febuxostat.]
[R03DA01, dyphylline, The serum concentration of the active metabolites of Dyphylline can be increased when Dyphylline is used in combination with Febuxostat.]
[N02CC01, sumatriptan, The excretion of Sumatriptan can be decreased when combined with Febuxostat.]
[N03AG01, valproic acid, The metabolism of Febuxostat can be decreased when combined with Valproic acid.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Febuxostat.]
[L02AA03, ethinyl estradiol, The metabolism of Febuxostat can be increased when combined with Ethinylestradiol.]
[L01CB01, etoposide, The excretion of Etoposide can be decreased when combined with Febuxostat.]
[C10AA03, pravastatin, The excretion of Pravastatin can be decreased when combined with Febuxostat.]
[M01CB01, gold sodium thiomalate, The metabolism of Febuxostat can be decreased when combined with Sodium aurothiomalate.]
[A05AA01, chenodeoxycholic acid, The metabolism of Febuxostat can be decreased when combined with Chenodeoxycholic acid.]
[L01BB06, clofarabine, The excretion of Clofarabine can be decreased when combined with Febuxostat.]
[L04AA40, cladribine, The excretion of Cladribine can be decreased when combined with Febuxostat.]
[N05CD03, flunitrazepam, The metabolism of Febuxostat can be decreased when combined with Flunitrazepam.]
[L01BC02, fluorouracil, The excretion of Fluorouracil can be decreased when combined with Febuxostat.]
[S01BC04, flurbiprofen, The metabolism of Febuxostat can be decreased when combined with Flurbiprofen.]
[V04CX02, folic acid, The excretion of Folic acid can be decreased when combined with Febuxostat.]
[C10AB04, gemfibrozil, The metabolism of Febuxostat can be decreased when combined with Gemfibrozil.]
[L01EA02, dasatinib, The excretion of Dasatinib can be decreased when combined with Febuxostat.]
[C01CA21, cafedrine, The serum concentration of the active metabolites of Cafedrine can be increased when Cafedrine is used in combination with Febuxostat.]
[A10BB01, glyburide, The excretion of Glyburide can be decreased when combined with Febuxostat.]
[L01EX02, sorafenib, The excretion of Sorafenib can be decreased when combined with Febuxostat.]
[L01CE02, irinotecan, The excretion of Irinotecan can be decreased when combined with Febuxostat.]
[M04AA01, allopurinol, The excretion of Allopurinol can be decreased when combined with Febuxostat.]
[C03AA03, hydrochlorothiazide, The therapeutic efficacy of Febuxostat can be decreased when used in combination with Hydrochlorothiazide.]
[C03AA02, hydroflumethiazide, The therapeutic efficacy of Febuxostat can be decreased when used in combination with Hydroflumethiazide.]
[L01CE01, topotecan, The excretion of Topotecan can be decreased when combined with Febuxostat.]
[S01BC01, indomethacin, The metabolism of Febuxostat can be decreased when combined with Indomethacin.]
[C10AA06, cerivastatin, The excretion of Cerivastatin can be decreased when combined with Febuxostat.]
[P02CF01, ivermectin, The excretion of Ivermectin can be decreased when combined with Febuxostat.]
[J02AB02, ketoconazole, The metabolism of Febuxostat can be decreased when combined with Ketoconazole.]
[V03AC03, deferasirox, The metabolism of Febuxostat can be decreased when combined with Deferasirox.]
[L01BA05, pralatrexate, The excretion of Pralatrexate can be decreased when combined with Febuxostat.]
[L01EA03, nilotinib, The excretion of Nilotinib can be decreased when combined with Febuxostat.]
[J05AF05, lamivudine, The excretion of Lamivudine can be decreased when combined with Febuxostat.]
[L04AX03, methotrexate, The excretion of Methotrexate can be decreased when combined with Febuxostat.]
[C03AA08, methyclothiazide, The therapeutic efficacy of Febuxostat can be decreased when used in combination with Methyclothiazide.]
[V04CG05, methylene blue, The metabolism of Febuxostat can be decreased when combined with Methylene blue.]
[R03DA05, aminophylline, The serum concentration of the active metabolites of Aminophylline can be increased when Aminophylline is used in combination with Febuxostat.]
[L01DB07, mitoxantrone, The excretion of Mitoxantrone can be decreased when combined with Febuxostat.]
[N06AA09, amitriptyline, The metabolism of Febuxostat can be decreased when combined with Amitriptyline.]
[B02BX05, eltrombopag, The metabolism of Febuxostat can be decreased when combined with Eltrombopag.]
[L01EX03, pazopanib, The excretion of Pazopanib can be decreased when combined with Febuxostat.]
[G03XC01, raloxifene, The excretion of Raloxifene can be decreased when combined with Febuxostat.]
[N03AB05, fosphenytoin, The metabolism of Febuxostat can be decreased when combined with Fosphenytoin.]
[M02AA17, niflumic acid, The metabolism of Febuxostat can be decreased when combined with Niflumic acid.]
[J01XE01, nitrofurantoin, The excretion of Nitrofurantoin can be decreased when combined with Febuxostat.]
[C04AD03, pentoxifylline, The serum concentration of the active metabolites of Pentoxifylline can be increased when Pentoxifylline is used in combination with Febuxostat.]
[N03AA02, phenobarbital, The metabolism of Febuxostat can be increased when combined with Phenobarbital.]
[N03AB02, phenytoin, The metabolism of Febuxostat can be increased when combined with Phenytoin.]
[C03AA05, polythiazide, The therapeutic efficacy of Febuxostat can be decreased when used in combination with Polythiazide.]
[J05AE03, ritonavir, The excretion of Ritonavir can be decreased when combined with Febuxostat.]
[C10AA08, pitavastatin, The excretion of Pitavastatin can be decreased when combined with Febuxostat.]
[C02CA01, prazosin, The excretion of Prazosin can be decreased when combined with Febuxostat.]
[N03AA03, primidone, The metabolism of Febuxostat can be increased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Febuxostat can be decreased when combined with Probenecid.]
[N01AX10, propofol, The metabolism of Febuxostat can be decreased when combined with Propofol.]
[J04AB02, rifampin, The metabolism of Febuxostat can be increased when combined with Rifampicin.]
[A07EC01, sulfasalazine, The excretion of Sulfasalazine can be decreased when combined with Febuxostat.]
[L01BB02, mercaptopurine, Febuxostat - azathioprine and mercaptopurine]
[L04AX01, azathioprine, Febuxostat - azathioprine and mercaptopurine]
